6533b82afe1ef96bd128c012

RESEARCH PRODUCT

CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset

Christiane GogMurielle MauerMarkus MoehlerC. KoehneDaniela E. AustArndt WeinmannManfred P. LutzThomas SchmittErik TanisThomas ThomaidisFelicitas RoelofsonFrederic FiteniAnnett Maderer

subject

Oncologymedicine.medical_specialtyColorectal cancerbusiness.industrymedicine.medical_treatmentMEDLINEHematologyGeneral MedicineDiseasemedicine.diseaseCXCR4OncologyInternal medicinePost-hoc analysismedicineRadiology Nuclear Medicine and imagingStage (cooking)businessAdjuvant

description

Adjuvant colon cancer (CC) therapy and survival have greatly evolved over the last decades. Research shifted towards a more biological tumour understanding and unlocked new therapies and disease mo...

https://doi.org/10.1080/0284186x.2021.1959057